Google
TRVN — TREVENA INC (Healthcare >> Biotechnology)
TRVN FAQ
What is TRVN's ROE?
TREVENA INC reports a Return on Equity (ROE) of 146.02%.
What is TRVN's dividend yield?
TREVENA INC offers a dividend yield of 0.00%.
What is TRVN's Deepscope Quality Score?
Deepscope rates TRVN's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy TRVN?
Deepscope's AI Timing Score for TRVN is 0 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does TRVN belong to?
TREVENA INC is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.
|
USD 0.01
Price
-0.00
(-0.90%)
Day Change
|
|
|---|
TRVN, the overall quality is not quite good ( Quality = 54) and the timing to buy is ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
ROA is relatively low.
ROE is decreasing significantly
ROA is too relatively low compare to ROE
Current growth of ROA was below our criteria.
Net profit margin is relatively low.
Historical net profit margin is relatively low.
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
In details, quality factors are not quite good , financial health is not good , and ability to make profit is not quite good , ...
| Quality Factors |
|
51% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.00 From 30 days period |
| News Score | 58 |
| Magic Formula Rank by ROA |
N/A
|
| Magic Formula Rank by ROE |
N/A
|
| Magic Formula Rank by ROIC |
N/A
|
| Price | 0.01 |
| PBV / Sector |
N/A / 4.75
|
| Earning Per Share | -39.41 |
| PE / Sector |
N/A / 17.65
|
| PEG or PE/Growth / Sector |
N/A / 0.52
|
| Average 1M Daily Value |
1.561990000000
GREAT
|
| Average 1W Daily Value |
4.890660000000
GREAT
|
| Timing Factors |
|
57% |
| Financial Health |
|
41% |
| Ability to Make Profit |
|
56% |
| Return to Investors |
|
4% |
| Registration Details |
| Analyze Date | 2026-06-09 09:40:12 |
| Symbol | TRVN |
| Name | TREVENA INC |
| Sector | Healthcare >> Biotechnology |
| Market | NASDAQ |
| Listed Shares | 0.86 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 0.01 / 9,000.42 |
| News, Concensus, ... |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: 955 Chesterbrook Boulevard, Chesterbrook, PA, United States, 19087
Phone: 610 354 8840
Website: https://www.trevena.com
Sector: Healthcare >> Biotechnology
Description: Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein biased mu-opioid receptor (MOR) ligand for the management of moderate-to-severe acute pain; TRV734, a small molecule G protein biased ligand of the MOR, which has completed phase I studies for the treatment of moderate-to-severe acute and chronic pain; and TRV045, a novel S1P modulator for managing chronic pain. Trevena, Inc. was incorporated in 2007 and is headquartered in Chesterbrook, Pennsylvania.
ME vs SECTOR Healthcare >> Biotechnology
Click a bubble to view stock details · Bubble size represents market capitalization share
